Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles
Author Information
Author(s): Christian Savard, Annie Drouin, Karine Bolduc, Marilène Laliberté-Gagné, Marie-Eve Dumas, Marie-Christine Majeau, Nathalie Leclerc, Denis Leclerc
Primary Institution: Laval University, Quebec City, Canada
Hypothesis
Can nanoparticles made of the coat protein of a plant virus (PapMV) improve the efficacy of the trivalent inactivated influenza vaccine?
Conclusion
The study found that seasonal flu vaccines adjuvanted with PapMV nanoparticles can induce universal protection against influenza.
Supporting Evidence
- PapMV nanoparticles improved the humoral response to TIV by increasing total IgG and IgG2a levels.
- Immunization with PapMV nanoparticles led to long-lasting protection against heterosubtypic influenza strains.
- The study demonstrated that PapMV nanoparticles can enhance the immune response to conserved influenza proteins.
Takeaway
Researchers used tiny particles from a plant virus to make the flu vaccine work better, helping protect against different types of the flu.
Methodology
Mice and ferrets were immunized with TIV alone or with PapMV nanoparticles, and their immune responses were measured.
Participant Demographics
Balb/C mice and ferrets were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website